Interferon-γ-Responsive Nonhematopoietic Cells Regulate the Immune Response to Mycobacterium tuberculosis

Immunity

Volumn 31, Issue 6, 2009, Pages 974-985

  Desvignes, Ludovic ^a   Ernst, Joel D ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

CELLIMMUNO; MOLIMMUNO

Indexed keywords

CATHELICIDIN; CD14 ANTIGEN; CELL ADHESION MOLECULE; CHEMOKINE RECEPTOR CCR1; COLONY STIMULATING FACTOR; CXCL1 CHEMOKINE; ENDOTHELIN 1; EPITHELIAL DERIVED NEUTROPHIL ACTIVATING FACTOR 78; GAMMA INTERFERON; GELATINASE B; INDOLEAMINE 2,3 DIOXYGENASE; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE; INTERLEUKIN 1 RECEPTOR TYPE II; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 23P19; INTERLEUKIN 6; LYMPHOTOXIN; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 1; STAT1 PROTEIN; STAT2 PROTEIN; STEFIN A; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 6; TRANSCRIPTION FACTOR T BET; TRANSPORTER ASSOCIATED WITH ANTIGEN PROCESSING 1; TRYPTOPHAN; TUMOR NECROSIS FACTOR;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BACTERIAL COUNT; BACTERIAL IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENDOTHELIUM CELL; ENZYME DEGRADATION; EPITHELIUM CELL; FEMALE; GENE OVEREXPRESSION; IMMUNE RESPONSE; IMMUNOREGULATION; INHIBITION KINETICS; LUNG ALVEOLUS EPITHELIUM; LUNG ENDOTHELIUM; MORTALITY; MOUSE; MYCOBACTERIUM TUBERCULOSIS; NEUTROPHIL CHEMOTAXIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TH17 CELL;

ANIMALS; BACTEREMIA; CELLS, CULTURED; ENDOTHELIAL CELLS; FEMALE; GENE EXPRESSION PROFILING; INDOLEAMINE-PYRROLE 2,3,-DIOXYGENASE; INTERFERON-GAMMA; INTERLEUKIN-17; INTERLEUKIN-23; KYNURENINE; LUNG; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MYCOBACTERIUM TUBERCULOSIS; NEUTROPHIL INFILTRATION; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PNEUMONIA, BACTERIAL; RECEPTORS, INTERFERON; RESPIRATORY MUCOSA; T-LYMPHOCYTES, HELPER-INDUCER; TUBERCULOSIS, PULMONARY;

EID: 71749103051     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.immuni.2009.10.007     Document Type: Article

References (58)

1. Banaiee N., Kincaid E.Z., Buchwald U., Jacobs Jr. W.R., and Ernst J.D. Potent inhibition of macrophage responses to IFN-gamma by live virulent Mycobacterium tuberculosis is independent of mature mycobacterial lipoproteins but dependent on TLR2. J. Immunol. 176 (2006) 3019-3027
2. Bermudez L.E., and Goodman J. Mycobacterium tuberculosis invades and replicates within type II alveolar cells. Infect. Immun. 64 (1996) 1400-1406
3. Bettelli E., Oukka M., and Kuchroo V.K. T(H)-17 cells in the circle of immunity and autoimmunity. Nat. Immunol. 8 (2007) 345-350
4. Brandacher G., Margreiter R., and Fuchs D. Clinical relevance of indoleamine 2,3-dioxygenase for alloimmunity and transplantation. Curr. Opin. Organ Transplant. 13 (2008) 10-15
5. Carlin J.M., Ozaki Y., Byrne G.I., Brown R.R., and Borden E.C. Interferons and indoleamine 2,3-dioxygenase: role in antimicrobial and antitumor effects. Experientia 45 (1989) 535-541
6. Christen S., Peterhans E., and Stocker R. Antioxidant activities of some tryptophan metabolites: possible implication for inflammatory diseases. Proc. Natl. Acad. Sci. USA 87 (1990) 2506-2510
7. Cooper A.M., Dalton D.K., Stewart T.A., Griffin J.P., Russell D.G., and Orme I.M. Disseminated tuberculosis in interferon gamma gene-disrupted mice. J. Exp. Med. 178 (1993) 2243-2247
8. Cruz A., Khader S.A., Torrado E., Fraga A., Pearl J.E., Pedrosa J., Cooper A.M., and Castro A.G. Cutting edge: IFN-gamma regulates the induction and expansion of IL-17-producing CD4 T cells during mycobacterial infection. J. Immunol. 177 (2006) 1416-1420
9. Davis J.M., and Ramakrishnan L. The role of the granuloma in expansion and dissemination of early tuberculous infection. Cell 136 (2009) 37-49
10. de Valliere S., and Barker R.D. Residual lung damage after completion of treatment for multidrug-resistant tuberculosis. Int. J. Tuberc. Lung Dis. 8 (2004) 767-771
11. Debbabi H., Ghosh S., Kamath A.B., Alt J., Demello D.E., Dunsmore S., and Behar S.M. Primary type II alveolar epithelial cells present microbial antigens to antigen-specific CD4+ T cells. Am. J. Physiol. Lung Cell. Mol. Physiol. 289 (2005) L274-L279
12. Ehrt S., Schnappinger D., Bekiranov S., Drenkow J., Shi S., Gingeras T.R., Gaasterland T., Schoolnik G., and Nathan C. Reprogramming of the macrophage transcriptome in response to interferon-gamma and Mycobacterium tuberculosis: signaling roles of nitric oxide synthase-2 and phagocyte oxidase. J. Exp. Med. 194 (2001) 1123-1140
13. Evans S.E., Scott B.L., Clement C.G., Larson D.T., Kontoyiannis D., Lewis R.E., Lasala P.R., Pawlik J., Peterson J.W., Chopra A.K., et al. Stimulated Innate Resistance of Lung Epithelium Protects Mice Broadly Against Bacteria and Fungi. Am. J. Respir. Cell Mol. Biol. (2009) 10.1165/rcmb.2008-0260OC in press. Published online March 27, 2009
14. Fieschi C., Dupuis S., Catherinot E., Feinberg J., Bustamante J., Breiman A., Altare F., Baretto R., Le Deist F., Kayal S., et al. Low penetrance, broad resistance, and favorable outcome of interleukin 12 receptor beta1 deficiency: medical and immunological implications. J. Exp. Med. 197 (2003) 527-535
15. Filipe-Santos O., Bustamante J., Chapgier A., Vogt G., de Beaucoudrey L., Feinberg J., Jouanguy E., Boisson-Dupuis S., Fieschi C., Picard C., and Casanova J.L. Inborn errors of IL-12/23- and IFN-gamma-mediated immunity: molecular, cellular, and clinical features. Semin. Immunol. 18 (2006) 347-361
16. Flynn J.L., Chan J., Triebold K.J., Dalton D.K., Stewart T.A., and Bloom B.R. An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection. J. Exp. Med. 178 (1993) 2249-2254
17. Gill W.P., Harik N.S., Whiddon M.R., Liao R.P., Mittler J.E., and Sherman D.R. A replication clock for Mycobacterium tuberculosis. Nat. Med. 15 (2009) 211-214
18. Gonzalez-Juarrero M., Shim T.S., Kipnis A., Junqueira-Kipnis A.P., and Orme I.M. Dynamics of macrophage cell populations during murine pulmonary tuberculosis. J. Immunol. 171 (2003) 3128-3135
19. Gutierrez M.G., Master S.S., Singh S.B., Taylor G.A., Colombo M.I., and Deretic V. Autophagy is a defense mechanism inhibiting BCG and Mycobacterium tuberculosis survival in infected macrophages. Cell 119 (2004) 753-766
20. Happel K.I., Lockhart E.A., Mason C.M., Porretta E., Keoshkerian E., Odden A.R., Nelson S., and Ramsay A.J. Pulmonary interleukin-23 gene delivery increases local T-cell immunity and controls growth of Mycobacterium tuberculosis in the lungs. Infect. Immun. 73 (2005) 5782-5788
21. Heseler K., Spekker K., Schmidt S.K., MacKenzie C.R., and Daubener W. Antimicrobial and immunoregulatory effects mediated by human lung cells: role of IFN-gamma-induced tryptophan degradation. FEMS Immunol. Med. Microbiol. 52 (2008) 273-281
22. Higgins D.M., Sanchez-Campillo J., Rosas-Taraco A.G., Lee E.J., Orme I.M., and Gonzalez-Juarrero M. Lack of IL-10 alters inflammatory and immune responses during pulmonary Mycobacterium tuberculosis infection. Tuberculosis (Edinb.) 89 (2009) 149-157
23. Jouanguy E., Lamhamedi-Cherradi S., Altare F., Fondaneche M.C., Tuerlinckx D., Blanche S., Emile J.F., Gaillard J.L., Schreiber R., Levin M., et al. Partial interferon-gamma receptor 1 deficiency in a child with tuberculoid bacillus Calmette-Guerin infection and a sibling with clinical tuberculosis. J. Clin. Invest. 100 (1997) 2658-2664
24. Katz J.B., Muller A.J., and Prendergast G.C. Indoleamine 2,3-dioxygenase in T-cell tolerance and tumoral immune escape. Immunol. Rev. 222 (2008) 206-221
25. Khader S.A., and Cooper A.M. IL-23 and IL-17 in tuberculosis. Cytokine 41 (2008) 79-83
26. Khader S.A., Bell G.K., Pearl J.E., Fountain J.J., Rangel-Moreno J., Cilley G.E., Shen F., Eaton S.M., Gaffen S.L., Swain S.L., et al. IL-23 and IL-17 in the establishment of protective pulmonary CD4+ T cell responses after vaccination and during Mycobacterium tuberculosis challenge. Nat. Immunol. 8 (2007) 369-377
27. Kotton D.N., Fabian A.J., and Mulligan R.C. Failure of bone marrow to reconstitute lung epithelium. Am. J. Respir. Cell Mol. Biol. 33 (2005) 328-334
28. Le A.V., and Broide D.H. Indoleamine-2,3-dioxygenase modulation of allergic immune responses. Curr. Allergy Asthma Rep. 6 (2006) 27-31
29. Leto T.L., and Geiszt M. Role of Nox family NADPH oxidases in host defense. Antioxid. Redox Signal. 8 (2006) 1549-1561
30. Lin Y., Zhang M., and Barnes P.F. Chemokine production by a human alveolar epithelial cell line in response to Mycobacterium tuberculosis. Infect. Immun. 66 (1998) 1121-1126
31. Linden A., Laan M., and Anderson G.P. Neutrophils, interleukin-17A and lung disease. Eur. Respir. J. 25 (2005) 159-172
32. MacMicking J.D., North R.J., LaCourse R., Mudgett J.S., Shah S.K., and Nathan C.F. Identification of nitric oxide synthase as a protective locus against tuberculosis. Proc. Natl. Acad. Sci. USA 94 (1997) 5243-5248
33. MacMicking J.D., Taylor G.A., and McKinney J.D. Immune control of tuberculosis by IFN-gamma-inducible LRG-47. Science 302 (2003) 654-659
34. McGeachy M.J., Chen Y., Tato C.M., Laurence A., Joyce-Shaikh B., Blumenschein W.M., McClanahan T.K., O'Shea J.J., and Cua D.J. The interleukin 23 receptor is essential for the terminal differentiation of interleukin 17-producing effector T helper cells in vivo. Nat. Immunol. 10 (2009) 314-324
35. Mehta P.K., Karls R.K., White E.H., Ades E.W., and Quinn F.D. Entry and intracellular replication of Mycobacterium tuberculosis in cultured human microvascular endothelial cells. Microb. Pathog. 41 (2006) 119-124
36. Mellor A.L., and Munn D.H. IDO expression by dendritic cells: tolerance and tryptophan catabolism. Nat. Rev. Immunol. 4 (2004) 762-774
37. Munn D.H., and Mellor A.L. Indoleamine 2,3-dioxygenase and tumor-induced tolerance. J. Clin. Invest. 117 (2007) 1147-1154
38. Nagabhushanam V., Solache A., Ting L.M., Escaron C.J., Zhang J.Y., and Ernst J.D. Innate inhibition of adaptive immunity: Mycobacterium tuberculosis-induced IL-6 inhibits macrophage responses to IFN-gamma. J. Immunol. 171 (2003) 4750-4757
39. Narui K., Noguchi N., Saito A., Kakimi K., Motomura N., Kubo K., Takamoto S., and Sasatsu M. Anti-infectious activity of tryptophan metabolites in the L-tryptophan-L-kynurenine pathway. Biol. Pharm. Bull. 32 (2009) 41-44
40. Nathan C., and Shiloh M.U. Reactive oxygen and nitrogen intermediates in the relationship between mammalian hosts and microbial pathogens. Proc. Natl. Acad. Sci. USA 97 (2000) 8841-8848
41. Parish T., and Stoker N.G. The common aromatic amino acid biosynthesis pathway is essential in Mycobacterium tuberculosis. Microbiology 148 (2002) 3069-3077
42. Pfefferkorn E.R. Interferon gamma blocks the growth of Toxoplasma gondii in human fibroblasts by inducing the host cells to degrade tryptophan. Proc. Natl. Acad. Sci. USA 81 (1984) 908-912
43. Pfefferkorn E.R., Rebhun S., and Eckel M. Characterization of an indoleamine 2,3-dioxygenase induced by gamma-interferon in cultured human fibroblasts. J. Interferon Res. 6 (1986) 267-279
44. Rapoza P.A., Tahija S.G., Carlin J.P., Miller S.L., Padilla M.L., and Byrne G.I. Effect of interferon on a primary conjunctival epithelial cell model of trachoma. Invest. Ophthalmol. Vis. Sci. 32 (1991) 2919-2923
45. Rivas-Santiago B., Contreras J.C., Sada E., and Hernandez-Pando R. The potential role of lung epithelial cells and beta-defensins in experimental latent tuberculosis. Scand. J. Immunol. 67 (2008) 448-452
46. Robbins R.A., Springall D.R., Warren J.B., Kwon O.J., Buttery L.D., Wilson A.J., Adcock I.M., Riveros-Moreno V., Moncada S., Polak J., et al. Inducible nitric oxide synthase is increased in murine lung epithelial cells by cytokine stimulation. Biochem. Biophys. Res. Commun. 198 (1994) 835-843
47. Romani L., Fallarino F., De Luca A., Montagnoli C., D'Angelo C., Zelante T., Vacca C., Bistoni F., Fioretti M.C., Grohmann U., et al. Defective tryptophan catabolism underlies inflammation in mouse chronic granulomatous disease. Nature 451 (2008) 211-215
48. Sana T.R., Janatpour M.J., Sathe M., McEvoy L.M., and McClanahan T.K. Microarray analysis of primary endothelial cells challenged with different inflammatory and immune cytokines. Cytokine 29 (2005) 256-269
49. Sauty A., Dziejman M., Taha R.A., Iarossi A.S., Neote K., Garcia-Zepeda E.A., Hamid Q., and Luster A.D. The T cell-specific CXC chemokines IP-10, Mig, and I-TAC are expressed by activated human bronchial epithelial cells. J. Immunol. 162 (1999) 3549-3558
50. Schaible U.E., Sturgill-Koszycki S., Schlesinger P.H., and Russell D.G. Cytokine activation leads to acidification and increases maturation of Mycobacterium avium-containing phagosomes in murine macrophages. J. Immunol. 160 (1998) 1290-1296
51. Schroder K., Hertzog P.J., Ravasi T., and Hume D.A. Interferon-gamma: an overview of signals, mechanisms and functions. J. Leukoc. Biol. 75 (2004) 163-189
52. Skold M., and Behar S.M. Tuberculosis triggers a tissue-dependent program of differentiation and acquisition of effector functions by circulating monocytes. J. Immunol. 181 (2008) 6349-6360
53. Teitelbaum R., Schubert W., Gunther L., Kress Y., Macaluso F., Pollard J.W., McMurray D.N., and Bloom B.R. The M cell as a portal of entry to the lung for the bacterial pathogen Mycobacterium tuberculosis. Immunity 10 (1999) 641-650
54. Ting L.M., Kim A.C., Cattamanchi A., and Ernst J.D. Mycobacterium tuberculosis inhibits IFN-gamma transcriptional responses without inhibiting activation of STAT1. J. Immunol. 163 (1999) 3898-3906
55. Wolf A.J., Linas B., Trevejo-Nunez G.J., Kincaid E., Tamura T., Takatsu K., and Ernst J.D. Mycobacterium tuberculosis infects dendritic cells with high frequency and impairs their function in vivo. J. Immunol. 179 (2007) 2509-2519
56. Wolf A.J., Desvignes L., Linas B., Banaiee N., Tamura T., Takatsu K., and Ernst J.D. Initiation of the adaptive immune response to Mycobacterium tuberculosis depends on antigen production in the local lymph node, not the lungs. J. Exp. Med. 205 (2008) 105-115
57. Yap G.S., and Sher A. Effector cells of both nonhemopoietic and hemopoietic origin are required for interferon (IFN)-gamma- and tumor necrosis factor (TNF)-alpha-dependent host resistance to the intracellular pathogen, Toxoplasma gondii. J. Exp. Med. 189 (1999) 1083-1092
58. Zelante T., Fallarino F., Bistoni F., Puccetti P., and Romani L. Indoleamine 2,3-dioxygenase in infection: the paradox of an evasive strategy that benefits the host. Microbes Infect. 11 (2009) 133-141